Effects of HGF gene polymorphisms and protein expression on transhepatic arterial chemotherapeutic embolism efficacy and prognosis in patients with primary liver cancer

References

• ChenJGZhangSWLiver cancer epidemic in China: past, present and futureSemin Cancer Biol2011211596921144900
   PubMed Web of Science ®Google Scholar
• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• PircherAMedingerMDrevsJLiver cancer: targeted future optionsWorld J Hepatol201132384421423913
   PubMedGoogle Scholar
• FanJHWangJBJiangYAttributable causes of liver cancer mortality and incidence in chinaAsian Pac J Cancer Prev201314127251725624460283
   PubMedGoogle Scholar
• Hernandez-AlcocebaRSangroBPrietoJGene therapy of liver cancerAnn Hepatol20076151417297424
   PubMedGoogle Scholar
• LoffroyRFavelierSCherblancVEstivaletLC-arm dual-phase cone-beam CT: a revolutionary real-time imaging modality to assess drug-eluting beads TACE success in liver cancer patientsQuant Imaging Med Surg20133419619924040615
   PubMedGoogle Scholar
• ZhangJJiangTYJiangBGRMP predicts survival and adjuvant TACE response in hepatocellular carcinomaOncotarget2015653432344225605019
   PubMedGoogle Scholar
• KesslerJASmithAGChaBSDouble-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathyAnn Clin Transl Neurol20152546547826000320
   PubMedGoogle Scholar
• SakaiKAokiSMatsumotoKHepatocyte growth factor and Met in drug discoveryJ Biochem2015157527128425770121
   PubMedGoogle Scholar
• PetriniIBiology of MET: a double life between normal tissue repair and tumor progressionAnn Transl Med2015368225992381
   PubMedGoogle Scholar
• MaJDeFrancesMCZouCJohnsonCFerrellRZarnegarRSomatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancerJ Clin Invest2009119347849119188684
   PubMedGoogle Scholar
• NakamuraMOnoYJKanemuraMHepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneumGynecol Oncol2015139234535426335595
   PubMed Web of Science ®Google Scholar
• HellingGWahlinSSmedbergMPlasma glutamine concentrations in liver failurePLoS One2016113e015044026938452
   PubMedGoogle Scholar
• LlovetJMBruCBruixJPrognosis of hepatocellular carcinoma: the BCLC staging classificationSemin Liver Dis199919332933810518312
   PubMed Web of Science ®Google Scholar
• BruixJShermanMPractice Guidelines Committee, American Association for the Study of Liver DiseasesManagement of hepatocellular carcinomaHepatology20054251208123616250051
   PubMed Web of Science ®Google Scholar
• EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer200945222824719097774
   PubMed Web of Science ®Google Scholar
• ApostolopolouERaftopoulosVTerzisKPissakiKPagoniMDelibasiSInfection probability score, apache ii and karnofsky scoring systems as predictors of infection onset in haematology-oncology patientsJ Clin Nurs20101911–121560156820384664
   PubMedGoogle Scholar
• LiuYHuHZhangCCo-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomasOncotarget2015635382573826926468983
   PubMedGoogle Scholar
• WuGWilsonGZhouGHebbardLGeorgeJQiaoLOct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinomaDiscov Med20152011021922926562475
   PubMedGoogle Scholar
• CaoBSuYOskarssonMNeutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal modelsProc Natl Acad Sci U S A200198137443744811416216
   PubMed Web of Science ®Google Scholar
• KawaguchiMKataokaHMechanisms of hepatocyte growth factor activation in cancer tissuesCancers (Basel)2014641890190425268161
   PubMedGoogle Scholar
• KaraFYildirimAGumusdereMKarataySYildirimKBakanEAssociation between hepatocyte growth factor (HGF) gene polymorphisms and serum HGF levels in patients with rheumatoid arthritisEurasian J Med201446317618125610321
   PubMedGoogle Scholar
• KarabulutSFTasFAkyuzFClinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinomaTumour Biol20143532327233324142532
   PubMedGoogle Scholar
• HuangFIChenYLChangCNYuanRHJengYMHepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasionCarcinogenesis20123361142114822436613
   PubMedGoogle Scholar
• LevreroMViral hepatitis and liver cancer: the case of hepatitis COncogene200625273834384716799625
   PubMed Web of Science ®Google Scholar
• SahebjadaSSchacheMRichardsonAJSnibsonGDaniellMBairdPNAssociation of the hepatocyte growth factor gene with keratoconus in an Australian populationPLoS One201491e8406724416191
   PubMed Web of Science ®Google Scholar
• PrystupaAKicinskiPSakJBoguszewska-CzubaraAToruń-JurkowskaAZałuskaWProinflammatory cytokines (il-1alpha, il-6) and hepatocyte growth factor in patients with alcoholic liver cirrhosisGastroenterol Res Pract2015201553261526448742
   PubMedGoogle Scholar
• Marin-SerranoERodriguez-RamosCDiaz-GarciaFMartín-HerreraLFernández-Gutiérrez-Del-AlamoCGirón-GonzálezJAHepatocyte growth factor and chronic hepatitis cRev Esp Enferm Dig2010102636537120575596
   PubMedGoogle Scholar
• MedinaJCavedaLSanz-CamenoPHepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis c-associated neoangiogenesisJ Hepatol200338566066712713878
   PubMedGoogle Scholar
• YamagamimHMoriyamaMMatsumuraHSerum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in c-viral chronic liver diseasesCancer200295482483412209727
   PubMedGoogle Scholar
• DaveauMScotteMFrancoisAHepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinomaMol Carcinog200336313014112619035
   PubMed Web of Science ®Google Scholar
• OgunwobiOOLiuCHepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathwaysClin Exp Metastasis201128872173121744257
   PubMed Web of Science ®Google Scholar
• HoshinoKSatohTKawaguchiYKuwanaMAssociation of hepatocyte growth factor promoter polymorphism with severity of interstitial lung disease in Japanese patients with systemic sclerosisArthritis Rheum20116382465247221520010
   PubMedGoogle Scholar
• MotoneMKatsuyaTIshikawaKAssociation between hepatocyte growth factor gene polymorphism and essential hypertensionHypertens Res200427424725115127882
   PubMedGoogle Scholar
• ToiyamaYMikiCInoueYOkugawaYTanakaKKusunokiMSerum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patientsInt J Cancer200912571657166219569242
   PubMed Web of Science ®Google Scholar
• HosodaHIzumiHTukadaYPlasma hepatocyte growth factor elevation may be associated with early metastatic disease in primary lung cancer patientsAnn Thorac Cardiovasc Surg20121811721959198
   PubMed Web of Science ®Google Scholar
• CanadasITausAGonzalezIHigh circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patientsOncotarget20145145246525625026301
   PubMedGoogle Scholar